Skip to main content
SpringerLink
Log in

Endoscopy and Endoscopic Ablative Therapies in GERD and Barrett’s Esophagus

  • Chapter
  • First Online:
Multidisciplinary Management of Gastroesophageal Reflux Disease

  • 664 Accesses

Abstract

Endoscopy is an important diagnostic and therapeutic tool for managing gastroesophageal reflux disease (GERD) and Barrett’s esophagus. Endoscopic findings such as erosive esophagitis, luminal narrowing, and metaplastic turnover of the epithelium are indicatives for GERD. Endoscopic fundoplication methods have been developed, some showed promising results, many left the market already. Biopsy sampling in GERD should be limited to cases with suspicion of Barrett’s metaplasia of at least 1 cm extension into the distal esophagus and withheld in case of massive inflammation. Surveillance of Barrett’s esophagus aims to detect early neoplasia. Advanced endoscopic imaging like chromoendoscopy or narrow-band imaging (NBI) can help to identify and characterize neoplastic lesions. Endoscopic treatment by endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), or radiofrequency ablation (RFA) aims to prevent progression into (advanced) esophageal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54(5):710–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, Casanova S, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett’s oesophagus in the general population: the Loiano-Monghidoro study. Gut. 2008;57(10):1354–9.

    Article  CAS  PubMed  Google Scholar 

  3. Murray L, Watson P, Johnston B. Risk of adenocarcinoma in Barrett’s oesophagus: population based study. BMJ. 2003;327:534–5.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med. 2011;365(15):1375–83.

    Article  CAS  PubMed  Google Scholar 

  5. Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am. 2002;11:235–56.

    Article  PubMed  Google Scholar 

  6. Shaheen NJ, Weinberg DS, Denberg TD, Chou R, Qaseem A, Shekelle P. Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians. Ann Intern Med. 2012;157(11):808–16.

    Article  PubMed  Google Scholar 

  7. Jafri SM, Arora G, Triadafilopoulos G. What is left of the endoscopic antireflux devices? Curr Opin Gastroenterol. 2009;25(4):352–7.

    Article  PubMed  Google Scholar 

  8. Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140(3):1084–91.

    Article  PubMed  Google Scholar 

  9. Numans ME, Lau J, de Wit NJ, Bonis PA. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med. 2004;140(7):518–27.

    Article  CAS  PubMed  Google Scholar 

  10. Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology. 1996;111(1):85–92.

    Article  CAS  PubMed  Google Scholar 

  11. Chu CL, Zhen YB, Lv GP, Li CQ, Li Z, Qi QQ, et al. Microalterations of esophagus in patients with non-erosive reflux disease: in-vivo diagnosis by confocal laser endomicroscopy and its relationship with gastroesophageal reflux. Am J Gastroenterol. 2012;107(6):864–74.

    Article  PubMed  Google Scholar 

  12. Vazquez-Elizondo G, Ngamruengphong S, Khrisna M, Devault KR, Talley NJ, Achem SR. The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther. 2013;38(10):1312–9.

    Article  CAS  PubMed  Google Scholar 

  13. Bajbouj M, Becker V, Neuber M, Schmid RM, Meining A. Combined pH-metry/impedance monitoring increases the diagnostic yield in patients with atypical gastroesophageal reflux symptoms. Digestion. 2007;76(3–4):223–8.

    Article  PubMed  Google Scholar 

  14. von Rahden BH, Stein HJ, Becker K, Liebermann-Meffert D, Siewert JR. Heterotopic gastric mucosa of the esophagus: literature-review and proposal of a clinicopathologic classification. Am J Gastroenterol. 2004;99(3):543–51.

    Article  Google Scholar 

  15. Hill LD, Kozarek RA, Kraemer SJ, Aye RW, Mercer CD, Low DE, et al. The gastroesophageal flap valve: in vitro and in vivo observations. Gastrointest Endosc. 1996;44(5):541–7.

    Article  CAS  PubMed  Google Scholar 

  16. Gonsalves N, Policarpio-Nicolas M, Zhang Q, Rao MS, Hirano I. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc. 2006;64:313–9.

    Article  PubMed  Google Scholar 

  17. ASGE Technology Committee, Thosani N, Goodman A, Manfredi M, Navaneethan U, Parsi MA, et al. Endoscopic anti-reflux devices [with videos]. Gastrointest Endosc. 2017;86:931–48.

    Article  Google Scholar 

  18. Testoni PA, Vailati C, Testoni S, Corsetti M. Transoral incisionless fundoplication [TIF 2.0] with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome. Surg Endosc. 2012;26:1425–35.

    Article  PubMed  Google Scholar 

  19. Huang X, Chen S, Zhao H, Zeng X, Lian J, et al. Efficacy of transoral incisionless fundoplication [TIF] for the treatment of GERD: a systematic review with metaanalysis. Surg Endosc. 2017;31:1032–44.

    Article  PubMed  Google Scholar 

  20. Zacherl J, Roy-Shapira A, Bonavina L, Bapaye A, Kiesslich R, Schoppmann SF, et al. Endoscopic anterior fundoplication with the Medigus ultrasonic surgical Endostapler [MUSE™] for gastroesophageal reflux disease: 6-month results from a multicenter prospective trial. Surg Endosc. 2015;29:220–9.

    Article  PubMed  Google Scholar 

  21. Kim HJ, Kwon CI, Kessler WR, Selzer DJ, McNulty G, et al. Long-term follow-up results of endoscopic treatment of gastroesophageal reflux disease with the MUSE™ endoscopic stapling device. Surg Endosc. 2016;30:3402–8.

    Article  PubMed  Google Scholar 

  22. Koch OO, Kaindlstorfer A, Antoniou SA, Spaun G, Pointner R, Swanstrom LL. Subjective and objective data on esophageal manometry and impedance pH monitoring 1 year after endoscopic full-thickness plication for the treatment of GERD by using multiple plication implants. Gastrointest Endosc. 2013;77:7–14.

    Article  PubMed  Google Scholar 

  23. Weitzendorfer M, Spaun GO, Antoniou SA, Witzel K, Emmanuel K, Koch OO. Clinical feasibility of a new full-thickness endoscopic plication device (GERDx™) for patients with GERD: results of a prospective trial. Surg Endosc. 2018;32(5):2541–9.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Kahrilas PJ. Radiofrequency energy treatment of GERD. Gastroenterology. 2003;125:970–3.

    Article  PubMed  Google Scholar 

  25. Perry KA, Banerjee A, Melvin WS. Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: a systematic review and meta-analysis. Surg Laparosc Endosc Percutan Tech. 2012;22:283–8.

    Article  PubMed  Google Scholar 

  26. Lipka S, Kumar A, Richter JE. No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and metaanalysis. Clin Gastroenterol Hepatol. 2015;13:1058–67.

    Article  PubMed  Google Scholar 

  27. Noar M, Squires P, Noar E, Lee M. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later. Surg Endosc. 2014;28:2323–33.

    Article  PubMed  Google Scholar 

  28. Inoue H, Ito H, Ikeda H, et al. Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study. Ann Gastroenterol. 2014;27:346–51.

    PubMed  PubMed Central  Google Scholar 

  29. Auyang ED, Carter P, Rauth T, Fanelli RD, SAGES Guidelines Committee. SAGES clinical spotlight review: endoluminal treatments for gastroesophageal reflux disease [GERD]. Surg Endosc. 2013;27:2658–72.

    Article  PubMed  Google Scholar 

  30. Danalioglu A, Cipe G, Toydemir T, Kocaman O, Ince AT, et al. Endoscopic stapling in comparison to laparoscopic fundoplication for the treatment of gastroesophageal reflux disease. Dig Endosc. 2014;26:37–42.

    Article  PubMed  Google Scholar 

  31. Weusten B, Bisschops R, Coron E, Dinis-Ribeiro M, Dumonceau JM, Esteban JM, et al. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy. 2017;49(2):191–8.

    Article  PubMed  Google Scholar 

  32. Pohl H, Pech O, Arash H, Stolte M, Manner H, May A, et al. Length of Barrett’s oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma. Gut. 2016;65(2):196–201.

    Article  PubMed  Google Scholar 

  33. Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett’s esophagus. Gastroenterology. 1993;105(1):40–50.

    Article  CAS  PubMed  Google Scholar 

  34. American Gastroenterological Association, Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology. 2011;140(3):1084–91.

    Article  Google Scholar 

  35. Sami SS, Subramanian V, Butt WM, Bejkar G, Coleman J, Mannath J, Ragunath K. High definition versus standard definition white light endoscopy for detecting dysplasia in patients with Barrett’s esophagus. Dis Esophagus. 2015;28(8):742–9.

    Article  CAS  PubMed  Google Scholar 

  36. Hoffman A, Kiesslich R, Bender A, Neurath MF, Nafe B, Herrmann G, et al. Acetic acid-guided biopsies after magnifying endoscopy compared with random biopsies in the detection of Barrett's esophagus: a prospective randomized trial with crossover design. Gastrointest Endosc. 2006;64(1):1–8.

    Article  CAS  PubMed  Google Scholar 

  37. Longcroft-Wheaton G, Brown J, Basford P, Cowlishaw D, Higgins B, Bhandari P, et al. Duration of acetowhitening as a novel objective tool for diagnosing high risk neoplasia in Barrett’s esophagus: a prospective cohort trial. Endoscopy. 2013;45(6):426–32.

    Article  CAS  PubMed  Google Scholar 

  38. Yoshida T, Inoue H, Usui S, Satodate H, Fukami N, Kudo SE. Narrow-band imaging system with magnifying endoscopy for superficial esophageal lesions. Gastrointest Endosc. 2004;59(2):288–95.

    Article  PubMed  Google Scholar 

  39. Curvers WL, Singh R, Song LM, Wolfsen HC, Ragunath K, Wang K, et al. Endoscopic tri-modal imaging for detection of early neoplasia in Barrett’s oesophagus: a multi-Centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system. Gut. 2008;57(2):167–72.

    Article  CAS  PubMed  Google Scholar 

  40. Kiesslich R, Gossner L, Goetz M, Dahlmann A, Vieth M, Stolte M, et al. In vivo histology of Barrett’s esophagus and associated neoplasia by confocal laser endomicroscopy. Clin Gastroenterol Hepatol. 2006;4(8):979–87.

    Article  PubMed  Google Scholar 

  41. Dolak W, Mesteri I, Asari R, Preusser M, Tribl B, Wrba F, et al. A pilot study of the endomicroscopic assessment of tumor extension in Barrett’s esophagus-associated neoplasia before endoscopic resection. Endosc Int Open. 2015;3(1):E19–28.

    PubMed  Google Scholar 

  42. Canto MI, Anandasabapathy S, Brugge W, Falk GW, Dunbar KB, Zhang Z, et al. Confocal Endomicroscopy for Barrett's esophagus or confocal Endomicroscopy for Barrett’s esophagus (CEBE) trial group. In vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia: a multicenter international randomized controlled trial (with video). Gastrointest Endosc. 2014;79(2):211–21.

    Article  PubMed  Google Scholar 

  43. Revilla-Nuin B, Parrilla P, Lozano JJ, et al. Predictive value of MicroRNAs in the progression of Barrett esophagus to adenocarcinoma in a long-term follow-up study. Ann Surg. 2013;257:886–93.

    Article  PubMed  Google Scholar 

  44. Timmer MR, Martinez P, Lau CT, et al. Derivation of genetic biomarkers for cancer risk stratification in Barrett’s oesophagus: a prospective cohort study. Gut. 2016;65:1602–10.

    Article  CAS  PubMed  Google Scholar 

  45. Boerwinkel DF, Di Pietro M, Liu X, et al. Endoscopic TriModal imaging and biomarkers for neoplasia conjoined: a feasibility study in Barrett’s esophagus. Dis Esophagus. 2014;27:435–43.

    Article  CAS  PubMed  Google Scholar 

  46. Pech O, May A, Manner H, Behrens A, Pohl J, Weferling M, et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology. 2014;146(3):652–660.e1.

    Article  PubMed  Google Scholar 

  47. Terheggen G, Horn EM, Vieth M, Gabbert H, Enderle M, Neugebauer A, et al. A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett’s neoplasia. Gut. 2017;66(5):783–93.

    Article  PubMed  Google Scholar 

  48. Manner H, May A, Kouti I, et al. Efficacy and safety of hybrid-APC for the ablation of Barrett’s esophagus. Surg Endosc. 2016;30:1364–70.

    Article  PubMed  Google Scholar 

  49. Prasad GA, Wang KK, Buttar NS, Wongkeesong LM, Lutzke LS, Borkenhagen LS. Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc. 2007;65(1):60–6.

    Article  PubMed  Google Scholar 

  50. Canto MI, Shaheen NJ, Almario JA, Voltaggio L, Montgomery E, Lightdale CJ. Multifocal nitrous oxide cryoballoon ablation with or without EMR for treatment of neoplastic Barrett’s esophagus (with video). Gastrointest Endosc. 2018;88(3):438–446.e2.

    Article  PubMed  Google Scholar 

  51. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003;58(6 Suppl):S3–43.

    Google Scholar 

  52. Uno Y, Munakata A. The non-lifting sign of invasive colon cancer. Gastrointest Endosc. 1994;40(4):485–9.

    Article  CAS  PubMed  Google Scholar 

  53. Hondo FY, Maluf-Filho F, Kishi HS, Uemura RS, Okawa L, Cecconello I, et al. Predictive factors for local recurrence and incomplete resection of early gastric cancer treated by endoscopic resection: a Western experience. Can J Gastroenterol. 2009;23(5):357–63.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Inoue H, Takeshita K, Hori H, Muraoka Y, Yoneshima H, Endo M. Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions. Gastrointest Endosc. 1993;39(1):58–62.

    Article  CAS  PubMed  Google Scholar 

  55. Soehendra N, Seewald S, Groth S, Omar S, Seitz U, Zhong Y, et al. Use of modified multiband ligator facilitates circumferential EMR in Barrett’s esophagus (with video). Gastrointest Endosc. 2006;63(6):847–52.

    Article  PubMed  Google Scholar 

  56. Zhou P, et al., editors. Atlas of digestive endoscopic resection. Berlin: Springer; 2014.

    Google Scholar 

  57. Oyama T, Tomori A, Hotta K, Morita S, Kominato K, Tanaka M, et al. Endoscopic submucosal dissection of early esophageal cancer. Clin Gastroenterol Hepatol. 2005;3(7 Suppl 1):S67–70.

    Article  PubMed  Google Scholar 

  58. Kim ER, Lee H, Min BH, Lee JH, Rhee PL, Kim JJ, et al. Effect of rescue surgery after non-curative endoscopic resection of early gastric cancer. Br J Surg. 2015;102(11):1394–401.

    Article  CAS  PubMed  Google Scholar 

  59. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14(2):113–23.

    Article  Google Scholar 

  60. Gotoda T, Yamamoto H, Soetikno RM. Endoscopic submucosal dissection of early gastric cancer. J Gastroenterol. 2006;41(10):929–42.

    Article  PubMed  Google Scholar 

  61. Park YM, Cho E, Kang HY, Kim JM. The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: a systematic review and metaanalysis. Surg Endosc. 2011;25(8):2666–77.

    Article  PubMed  Google Scholar 

  62. Sakamoto T, Mori G, Yamada M, Kinjo Y, So E, Abe S, et al. Endoscopic submucosal dissection for colorectal neoplasms: a review. World J Gastroenterol. 2014;20(43):16153–8.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009;360:2277–88.

    Article  CAS  PubMed  Google Scholar 

  64. Phoa KN, Pouw RE, Bisschops R, et al. Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II). Gut. 2016;65:555–62.

    Article  CAS  PubMed  Google Scholar 

  65. Phoa KN, van Vilsteren FG, Weusten BL, Bisschops R, Schoon EJ, Ragunath K, Fullarton G, Di Pietro M, Ravi N, Visser M, Offerhaus GJ, Seldenrijk CA, Meijer SL, ten Kate FJ, Tijssen JG, Bergman JJ. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA. 2014;311:1209–17.

    Article  CAS  PubMed  Google Scholar 

  66. Qumseya BJ, Wani S, Desai M, et al. Adverse events after radiofrequency ablation in patients with Barrett’s esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14:1086–1095 e6.

    Article  PubMed  Google Scholar 

  67. van Vilsteren FG, Alvarez Herrero L, Pouw RE, et al. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett’s esophagus with early neoplasia: a prospective multicenter study. Endoscopy. 2013;45:516–25.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

    Werner Dolak

Authors
  1. Werner Dolak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Werner Dolak .

Editor information

Editors and Affiliations

  1. Department of General Surgery, Medical University of Vienna, Vienna, Austria

    Sebastian F. Schoppmann

  2. Reflux & Health Care, Vienna, Austria

    Martin Riegler

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dolak, W. (2021). Endoscopy and Endoscopic Ablative Therapies in GERD and Barrett’s Esophagus. In: Schoppmann, S.F., Riegler, M. (eds) Multidisciplinary Management of Gastroesophageal Reflux Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-53751-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-53751-7_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-53750-0

  • Online ISBN: 978-3-030-53751-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation